This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
New Strong Sell Stocks for November 1st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Adtalem's (ATGE) Q1 Earnings Miss Estimates, Down Y/Y
by Zacks Equity Research
Higher investments in marketing and student recruitment hurt Adtalem's (ATGE) Q1 earnings.
Adtalem Global Education (ATGE) Lags Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Adtalem (ATGE) delivered earnings and revenue surprises of -26.09% and -15.83%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Adtalem Confirms Talks With YDUQS Over Brazil Operations Sale
by Zacks Equity Research
Adtalem (ATGE) intends to explore strategic alternatives for its Brazil operations.
Adtalem (ATGE) Down 20.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Adtalem (ATGE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Adtalem's RUSM Partners With CSUDH, Boosts Physician Diversity
by Zacks Equity Research
Adtalem Global Education's (ATGE) Ross University School of Medicine collaborates with California State University to address Hispanic-American physician diversity in the United States.
Adtalem's (ATGE) Q4 Earnings Beat Estimates, Enrollment Up
by Zacks Equity Research
Strong demand and performance of students help Adtalem Global Education (ATGE) to post improved fiscal fourth-quarter 2019 results.
Adtalem Global Education (ATGE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Adtalem (ATGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Adtalem's (ATGE) New Texas Campus to Address Nursing Shortage
by Zacks Equity Research
Adtalem (ATGE) opens fourth campus in Texas and 22nd in the United States.
American Public Education (APEI) Q2 Earnings Match Estimates
by Zacks Equity Research
Lower contribution from HCN and APUS affects American Public Education's (APEI) second-quarter 2019 results.
Strategic Education's (STRA) Q2 Earnings & Revenues Beat
by Zacks Equity Research
Strong performance across the board aids Strategic Education (STRA) to post better-than-expected Q2 earnings.
Adtalem's (ATGE) ACAMS Unit Partners With MIM for Malta
by Zacks Equity Research
Adtalem Global Education's (ATGE) ACAMS unit is set to deliver CAMS certification in Malta in conjugation with MIM.
Adtalem Arm Partners With Dillard, Boosts Physician Diversity
by Zacks Equity Research
Adtalem Global Education's (ATGE) unit, Ross University School of Medicine collaborates with Dillard to address African-American physician diversity in the United States.
Adtalem (ATGE) Acquires Financial Services Unit of OnCourse
by Zacks Equity Research
Adtalem Global Education (ATGE) adds OnCourse to its financial services portfolio.
New Strong Sell Stocks for June 3rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Why Is Adtalem (ATGE) Down 12% Since Last Earnings Report?
by Zacks Equity Research
Adtalem (ATGE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New Strong Sell Stocks for May 23rd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
New Strong Sell Stocks for May 21st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Adtalem (ATGE) Extends BSN Sessions to Tap Growing Demand
by Zacks Equity Research
Adtalem Global Education's (ATGE) BSN degree program will be offered during evenings and weekends in order to serve the growing demand for nurses.
Adtalem's (ATGE) Q3 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Adtalem's (ATGE) fiscal third-quarter 2019 segmental growth is partially offset by currency headwinds and delays in government funding.
Adtalem Global Education (ATGE) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Adtalem (ATGE) delivered earnings and revenue surprises of 4.62% and -2.21%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Adtalem Global Education (ATGE) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Adtalem (ATGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Adtalem to Buy OnCourse Learning's Financial Services Unit
by Zacks Equity Research
Adtalem's (ATGE) buyout of OnCourse Learning's financial services business is likely to strengthen its foothold across the governance, risk and compliance sector.
ATGE or STRA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ATGE vs. STRA: Which Stock Is the Better Value Option?
Is Adtalem Global Education (ATGE) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.